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Rationale: Cannabis use is typically initiated during adolescence, and different studies 
suggest that adolescent cannabinoid exposure may increase the risk for drug addiction in 
adulthood.    
Objectives: This study investigated the effects of adolescent exposure to the main 
psychoactive component of cannabis, ∆9-tetrahydrocannabinol (THC), in the reinforcing 
properties of nicotine in adult male mice. Possible alterations in relapse to nicotine-
seeking behaviour in adult animals due to THC adolescent exposure were also evaluated.  
Methods: Adolescent mice were exposed to escalating doses of THC from PND35 to 
PND49. When mice reached adulthood (PND70), surgical procedures were applied for 
further behavioural evaluation. Nicotine self-administration sessions were conducted 
consecutively for 10 days. Following extinction, mice were tested for cue- and stress-
induced reinstatement of nicotine-seeking behaviour.         
Results: Adolescent THC treatment did not modify acquisition and extinction of nicotine 
self-administration in adulthood. Moreover, THC exposure did not alter relapse to 
nicotine seeking induced by stress or nicotine-associated cues.  
Conclusions: These results suggest that a history of exposure to THC during adolescence 
under these particular conditions does not modify the reinforcing effects and seeking 











Cannabis remains the most widely used illicit substance worldwide. The regular use of 
cannabis often begins during adolescence which is a vulnerable period of brain 
development. During adolescence, several neurotransmitter systems including the 
endocannabinoid system undergo extensive reorganization to promote the maturation of 
the central nervous system (Fernández-Ruiz et al. 2000; Harkany et al. 2007).  Adolescent 
cannabis exposure might affect the development of the endocannabinoid system and 
induce neurobiological changes that affect adult brain function (Higuera-Matas et al. 
2015). In agreement, preclinical and human clinical studies suggest that exposure to 
cannabinoids during adolescence may increase the risk for the appearance of 
neuropsychiatric diseases in adult life including emotional dysregulation, psychotic-like 
symptoms, cognitive deficits, and increased addiction vulnerability (Renard et al. 2016; 
Spear, 2016).  
Taking into account these findings, a gateway drug hypothesis was postulated suggesting 
that adolescent cannabis use can increase the risk for subsequent use of addictive drugs 
later in life (Fergusson et al. 2006; Fergusson and Boden, 2008). However, it is 
controversial whether the facilitation of later drug abuse in humans could be due to 
adolescent use of cannabis or because non-pharmacological factors predispose certain 
individuals to addiction in general (Morral et al. 2002; MacCoun, 2006; Vanyukov et al. 
2012). Indeed, the interaction between cannabis consumption and genetic or 
environmental factors during adolescence may have a crucial influence in the detrimental 
effects of this drug in adulthood (Rubino and Parolaro, 2016), since most psychiatric 
disorders involve multiple ethiopathological factors (Caspi and Moffitt, 2006). A direct 
effect of cannabis exposure can be tested in animal models by exposing rodents to ∆9-
tetrahydrocannabinol (THC) and later allowing them to self-administer another drug. 
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Changes in the self-administration behaviour of these rodents can be attributed to the 
effects of the prior drug exposure.  
Some studies have shown increased opioid sensitivity in adult animals exposed to THC 
during the adolescence by using this experimental approach. Heroin self-administration 
was greater in THC-exposed rats as compared to control animals (Ellgren et al. 2007), 
although no changes were observed in a later study (Stopponi et al. 2014). Moreover, cue- 
(Tomasiewicz et al. 2012) and yohimbine-induced reinstatement of heroin-seeking 
behaviour (Stopponi et al. 2014) were stronger in THC treated animals that in controls. 
Adolescent THC treatment increased self-administration of the synthetic cannabinoid 
WIN55,212-2 in adulthood (Scherma et al. 2016), suggesting also an increased risk of 
subsequent cannabis use.          
Tobacco consumption is one of the main public health problems worldwide and 
represents a leading cause of preventable deaths in most developed countries. In this 
context, an increased risk of tobacco dependence in adulthood could be a crucial 
detrimental consequence of cannabis adolescent use (Patton et al. 2005). While cannabis 
and tobacco are often co-use (Agrawal et al. 2008) epidemiological evidence suggests 
that cannabis consumption sometimes precedes regular tobacco use suggesting that THC 
consumption by teenagers could increase the risk for developing tobacco dependence 
when they reach young adulthood (Patton et al. 2005; Badiani et al. 2015).  However, to 
the best of our knowledge, no animal study has evaluated possible modifications in the 




Materials & Methods 
Animals 
Experiments were performed using adolescent male C57BL/6J mice (Charles River, 
France), housed 4 per cage in a room with controlled temperature (21 ± 1°C), and 
humidity (55 ± 10%) and with a normal 12 h light/dark cycle (lights on 8:00 AM). Food 
and water were available ad libitum. Before starting with the nicotine self-administration 
training sessions, mice were single-housed, switched to reversed cycle (lights off 8:00 
AM) and habituated for 1 week to the new conditions. Animal procedures were conducted 
in accordance with the guidelines of the European Communities Directive 2010/63/EU 
regulating animal research, the local ethical committee (CEEA-IMAS-UPF), and the 
statement of compliance with standards for use of laboratory animals by foreign 
institutions no. A5388-01 approved by the National Institutes of Health (USA). 
Drugs 
THC stored at 100 mg/ml in ethanol (THC-Pharm-GmbH, Germany) was dissolved in 
5% Tween-80 and physiological saline solution, and administered by subcutaneous (sc) 
route in a volume of 5 ml/kg of body weight at the doses of 3, 6 and 12 mg/kg. (-)-Nicotine 
hydrogen tartrate salt ((-)-1-methyl-2(3-pyridyl) pyrrolidine; Sigma) was dissolved in 
physiological saline (0.9% NaCl), adjusted to pH 7.4 and contingently administered by 
intravenous (iv) route at the dose of 30 μg/kg per infusion (free base). Ketamine 
hydrochloride (100 mg/kg; Imalgène 1000) and xylazine hydrochloride (20 mg/kg; 
Sigma) were mixed and diluted in ethanol (5%) and saline (95%). This anaesthetic 
mixture was administered intraperitoneally (ip) in a volume of 10 ml/kg body weight. 
Thiopental sodium (5 mg/ml; Braun Medical S.A.) was dissolved in distilled water and 
delivered in a volume of 0.05 ml through the iv catheter. 
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Adolescent THC treatment 
We evaluated the long-term effects of adolescent THC exposure in nicotine self-
administration, extinction and cue- or stress-induced reinstatement of nicotine-seeking 
behaviour during adulthood. The adolescence period, defined as the complete time span 
from childhood (shortly before puberty) to adulthood, was considered as previously 
reported (Rubino et al. 2008; Cadoni et al. 2015). Starting at PND 35, mice were 
administered with escalating doses of THC (PND 35–39: 3 mg/kg, PND 40–44: 6 mg/kg, 
and PND 45–49: 12 mg/kg) or vehicle during 15 days in order to counter the development 
of drug tolerance (Renard et al. 2017) (Fig. 1a). These doses were based on previous 
studies (Rubino et al. 2008; Llorente-Berzal et al. 2013; Scherma et al. 2016; Bruijnzeel 
et al. 2019). Moreover, similar to previous studies (Quinn et al. 2008; Llorente-Berzal et 
al. 2013; Saravia et al. 2019) animals remained undisturbed from PND 50 to 69, and they 
underwent surgical procedures at PND 70 for further behavioural evaluation (Fig. 1a).  
Nicotine self-administration 
Jugular vein catheterization. Mice were anesthetized with a ketamine/xylazine mixture 
and then implanted with indwelling iv silastic catheters in their right jugular vein as 
previously described (Soria et al. 2005). Briefly, silicone tubing of 6 cm long (0.3mm 
inner diameter, 0.6mm outer diameter; Silastic, Dow Corning) was fitted to a 22-gauge 
steel cannula (Semat) bent at a right angle and then embedded in a dental cement disk 
with an underlying nylon mesh. The catheter tubing was inserted 1.1 cm into the right 
jugular vein and anchored with suture. The remaining tubing ran subcutaneously to the 
cannula, which exited at the midscapular region. All incisions were sutured and coated 
with local antibiotic (Bactroban, GlaxoSmithKline). After surgery, mice were left to 
recover for 5-7 days before initiation of self-administration sessions. 
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Apparatus. The experiments were conducted in mouse operant chambers (model ENV-
307A-CT; Med Associates Inc.) equipped with two holes, one randomly selected as the 
active hole and the other as the inactive hole. Pump noise and stimuli lights (cues), one 
located inside the active hole and the other above it, were paired with the delivery of the 
reinforcer. Nicotine (30 μg/kg/infusion) was delivered in a volume of 23.5 μl over 2 s via 
a syringe mounted on a microinfusion pump and connected via flexible polymer tubing 
to a single channel liquid swivel and to the mouse iv catheter. 
Nicotine self-administration training. Operant model procedure was applied similarly to 
previous reports (Plaza-Zabala et al. 2013). Daily self-administration sessions of 1 h 
duration were conducted consecutively for 10 days. Mice were trained under a fixed ratio 
1 schedule of reinforcement with a 10-s time-out. Each daily session started with a 
priming injection of the drug. The stimuli light together with the pump noise signalled 
delivery of nicotine infusion. During the 10-s time-out period, the cue light was off and 
no reward was provided after active nose-poking. The session was terminated after 50 
reinforcers were delivered or after 1 h, whichever occurred first. The criteria for the 
acquisition of self-administration behaviour were achieved when in three consecutive 
sessions: (1) mice maintained a stable responding with <20% deviation from the mean of 
the total number of reinforcers earned (80% stability); (2) at least 75% responding on the 
active hole, and (3) a minimum of 6 reinforcers per session. The patency of iv catheters 
was evaluated at the end of nicotine self-administration training by an infusion of 0.05 ml 
of thiopental sodium through the catheter. If prominent signs of anaesthesia were not 
present immediately after, the mouse was removed from the experiment. Only mice with 
patent catheter that achieved all acquisition criteria were moved to the extinction phase. 
Extinction. Animals were allowed to rest for 1 day after thiopental testing. During the 
extinction period, nicotine and environmental cues were not delivered after nose-poking 
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in the active hole. Mice were subjected to 1 h daily sessions 6 days per week for 20 days. 
During this period, mice achieved the extinction criterion when active responses were 
<35% of the mean responses obtained during the 3 last days of nicotine self-
administration across 3 consecutive extinction sessions. Only mice that reached the 
extinction criterion were evaluated for reinstatement. These mice were equally distributed 
in two groups considering the time required for achieving the extinction criterion and the 
mean responses during acquisition: one group was tested for cue-induced reinstatement 
and the other for stress-induced reinstatement. 
Cue-induced reinstatement of nicotine-seeking behaviour. One day after reaching the 
extinction criterion, a group of mice was tested in a single cue-induced reinstatement 
session that lasted for 1 h. At the beginning of the session, mice were re-exposed to the 
pump noise and stimuli lights (environmental cues) for 2 s, after which each active nose-
poke led to the presentation of the same environmental cues. Nicotine was not available 
through the entire session.  
Stress-induced reinstatement of nicotine-seeking behaviour. Another group of mice was 
exposed to acute stress, consisting on receiving intermittent footshock stimuli (5 
footshocks separated by 1-min periods) at an intensity of 0.22 mA during 5 min 
immediately before the reinstatement session, as previously described (Martín-García et 
al. 2009). Test for reinstatement was conducted under the same conditions used in the 
extinction phase.  
The total number of animals used in the different experimental phases is summarized in 
Fig. 1b.  
Data Analysis 
Two-way ANOVA with repeated measures was used to analyse the effect of THC 
treatment on body weight, with treatment as between-subject factor and day as within-
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subject factor. Newman-Keuls comparisons were performed as post hoc analysis. For the 
evaluation of the acquisition of nicotine self-administration and extinction three-way 
ANOVA with repeated measures was employed (treatment as between-subject factor; 
hole and day as within-subject factors). Only within factors hole and day were considered 
in case that the interaction with treatment factor resulted non-significant. Subsequent post 
hoc comparisons (Newman-Keuls) were used for each day of training in the presence of 
significant interaction between factors. A similar analysis was applied to evaluate the 
reinstatement elicited by stress exposure or by presentation of nicotine-associated cues in 
mice extinguished from operant behaviour (with experimental phase and hole as within-
subject factors, and treatment as between-subject factor). χ2 test with Yates’ correction 
for low observed frequencies was used to compare the percentage of acquisition and 
extinction between animals subjected to THC or vehicle during adolescence. All the 
animals reaching the reinstatement phase were included in this analysis. The level of 






Reduced body weight after adolescent THC treatment is still present in adulthood  
Adolescent male mice were treated with escalating doses of THC or vehicle for 15 days 
(PND 35–39: 3 mg/kg, PND 40–44: 6 mg/kg, and PND 45–49: 12 mg/kg) (Fig. 1a). Body 
weight was assessed daily throughout THC treatment and right before the surgical 
procedures required for behavioural testing in the adulthood (PND70). As displayed in 
Fig. 2a, the weight gain of mice exposed to THC was lower than that of vehicle-treated 
animals during adolescent treatment (two-way ANOVA with repeated measures: 
significant interaction of treatment × day factors: F(14,980)=22.12, P<0.001), in agreement 
with previous reports employing similar protocols (Rubino et al. 2008; Stopponi et al. 
2014; Saravia et al. 2019). Post hoc comparisons revealed significant differences in body 
weight from day 10 of treatment (days 10-12, P<0.05; days 13-15, P<0.01). These 
differences were still present when mice reached adulthood (PND70) (P<0.01), probably 
as a residual effect from the treatment period since weight gain was not significantly 
different between THC- and vehicle-exposed groups (Fig. 2b).  
 
Adolescent THC treatment does not affect acquisition and extinction of nicotine self-
administration in adulthood 
Mice previously exposed to THC or vehicle during adolescence were trained to self-
administer nicotine (30 μg/kg per infusion) during 10 consecutive days. An increase in 
responding on the active hole developed over sessions in both vehicle- and THC-treated 
mice, whereas responding on the inactive hole remained at low levels (Fig. 3a), indicating 
a progress in operant responding for nicotine (two-way ANOVA with repeated measures: 
significant interaction of hole × day factors (F(9,414)=20.38, P<0.01). Vehicle- and THC-
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exposed mice displayed similar responding across days, and the total amount of nicotine 
consumed by both groups resulted identical (6.3 ± 0.5 and 6.32 ± 0.5 mg/kg, respectively; 
Fig. 3b). Acquisition criteria were achieved by 81% of vehicle-exposed mice and 100% 
of THC-treated mice (Yates’s χ2=2.72, p=0.09), and both groups required the same time 
to acquire operant responding for nicotine (7.3 ± 0.4 days) (Fig. 3c and 3d). Mice that met 
the acquisition criteria for nicotine self-administration behaviour underwent an extinction 
schedule for 20 sessions (Fig. 3e). The extinction criterion was achieved by 90% of mice 
treated with vehicle in 7.3 ± 0.7 days and by 86% of THC-exposed mice in 7.5 ± 0.8 days, 
indicating that both groups displayed the same ability to extinguish nicotine self-
administration (Fig. 3f and g).  
 
THC exposure during adolescence does not influence cue- nor footshock-induced 
reinstatement of nicotine-seeking behaviour in adulthood 
Animals that met the extinction criterion were tested for reinstatement of nicotine-seeking 
behaviour. Reinstatement studies were performed using a between-subjects design. Thus, 
different groups of mice were tested for reinstatement by exposure to either 
environmental cues or footshock stress. When allocating animals to different groups for 
reinstatement evaluation, we excluded any possible bias of nicotine acquisition levels by 
performing a two-way ANOVA with repeated-measures analysis. A significant effect of 
training day was revealed (F(9,297)=15.12, P<0.001), but not of the different experimental 
groups selected (F(3,33)=0.45, n.s.) nor interaction between both factors (F(27,297)=0.57, 
n.s.), indicating that the different groups of mice tested for reinstatement were similar in 
terms of previous self-administration levels. Mice exposed to nicotine-associated cues 
reinstated a previously extinguished nicotine-seeking behaviour (Fig. 4a), as observed in 
previous studies (Plaza-Zabala et al. 2013). Importantly, no differences were observed 
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between reinstatement levels displayed by THC- and vehicle-treated mice, as revealed by 
three-way ANOVA with repeated measures showing a significant effect of experimental 
phase and hole and their interaction (F(1,17)=61.30, P<0.001; F(1,17)=57.23, P<0.001; 
F(1,17)=68.80, P<0.001 respectively), but not of treatment (F(1,17)=0.46, n.s.). Similarly, 
footshock-stress exposure induced reinstatement of nicotine-seeking behaviour in mice 
previously treated with either THC or vehicle (Fig. 4b). Three-way ANOVA confirmed 
that THC treatment exerted no effect in footshock-induced responding (F(1,16)=3.79, n.s.), 
but a robust reinstatement of nicotine-seeking was further supported by significant effects 
of experimental phase, hole and their interaction (F(1,16)=43.83, P<0.001; F(1,16)=19.83, 
P<0.001; F(1,16)=37.99, P<0.001 respectively). Notably, reinstatement levels were lower 
after footshock-stress exposure than those observed after nicotine-associated cue 
presentation, in agreement with previous reports (Plaza-Zabala et al. 2010). These data 
suggest that adolescent THC exposure does not alter relapse to nicotine-seeking in the 





This study evaluated the effects of adolescent THC exposure in the addictive properties 
of nicotine in adulthood. The reinforcing effects of nicotine were not modified as revealed 
the lack of changes in the nicotine self-administration paradigm. The reinstatement of 
nicotine-seeking behaviour induced by footshock-stress and nicotine-associated cues was 
also similar between adolescent THC treated and control mice.  These data suggest that 
adolescent cannabinoid exposure would not be associated to increased tobacco 
consumption later in life.  
Mice were treated with escalating doses of THC from PND35 to PND49. This adolescent 
THC exposure regimen was similar to that used in previous experiments carried out in 
rodents (Rubino et al. 2008; Llorente-Berzal et al. 2013; Cadoni et al. 2015; Saravia et al. 
2019). The use of similar THC exposure regimens facilitates comparisons among 
different preclinical studies. However, doses usually used in preclinical studies are higher 
than those that would be consumed voluntarily, and greater than those observed in human 
smoking cannabis. Rodent models are limited with respect to modeling human substance 
abuse, including doses and duration of substance intake during adolescence (Bruijnzeel 
et al. 2019), and it would be important to address such limitations experimentally for 
instance by using cannabinoid self-administration models (Kirschmann et al. 2017).  
The weight gain of mice treated with THC was lower than those exposed to vehicle, as 
previously reported (Rubino et al. 2008; Stopponi et al. 2014; Scherma et al. 2016; 
Saravia et al. 2019). An anxiogenic-like effect induced by a high dose of THC could 
explain the observed changes in body weight. Indeed, one week after the finishing of the 
treatment, a previous study demonstrated the existence of an anxiety-like behaviour that 
was higher in adolescent rodents exposed to THC compared to controls (Stopponi et al. 
2014). Non-specific inhibition of ingestion, secondary to the sedative effects of THC 
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could also be involved in this effect on body weight. In addition, epidemiological studies 
show that the prevalence of obesity is lower in cannabis users than in nonusers (Le Strat 
and Le Foll, 2011). This difference was not accounted for by tobacco smoking status and 
was still present after adjusting for variables such as sex and age (Le Strat and Le Foll, 
2011), suggesting a direct effect related to exposure to the THC present in cannabis 
smoke. In agreement, chronic THC treatment reduced energy intake and prevented high 
fat diet-induced increases in body weight and adiposity in adult male mice (Cluny et al. 
2015), an effect possibly related to changes in gut microbiota. Intriguingly, these effects 
are paradoxical since blockade of cannabinoid CB1 receptors with rimonabant led to the 
development of a successful therapeutic approach for obesity (Le Foll et al. 2013) by 
inducing weight loss and improving metabolic profile. 
Epidemiological evidence suggests that prior cannabis use increases the likelihood of 
becoming dependent on tobacco (Patton et al. 2005; Timberlake et al. 2007; Badiani et 
al. 2015). Numerous studies in adult rodents also demonstrate that treatment with 
cannabinoid receptor ligands can modulate the addictive properties of nicotine (Solinas 
et al. 2008; Maldonado and Berrendero, 2010). Cannabinoid antagonists reduce the 
rewarding effects of nicotine as shown by behavioural and neurochemical approaches 
(Cohen et al. 2002; Le Foll and Goldberg, 2004) while cannabinoid agonists enhance 
nicotine reward and reinstate nicotine-seeking behaviour (Gamaleddin et al. 2012). 
Congruent with this, prior exposure to THC increased the addictive properties of nicotine 
in adult rats (Panlilio et al. 2013). Thus, the percentage of rats that acquired the nicotine 
self-administration behaviour was 94% in THC-exposed animals and only 65% in 
vehicle-treated animals. In this study, THC was administered for 3 days in adult animals, 
and nicotine self-administration experiments started 1 week following the last THC 
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injection (Panlilio et al. 2013). However, whether adolescent THC affects nicotine reward 
and relapse later in life remains to be investigated.  
Under our experimental conditions, adolescent THC exposure did not alter the 
performance of intravenous nicotine self-administration in adulthood. Control and THC 
treated mice showed similar number of infusions in the active hole and required the same 
time to acquire operant responding for nicotine. In agreement, THC treatment during 
adolescence did not modify behavioural responses induced by amphetamine in adult rats 
(Ellgren et al. 2004). On the contrary, there is evidence that adolescent THC exposure 
may increase the vulnerability and reward sensitivity to at least some psychoactive drugs 
when tested in adulthood. Thus, chronic THC exposure during adolescence increased 
opioid self-administration in adult male rats (Ellgren et al. 2007; Tomasiewicz et al. 
2012). This effect was associated with increased μ-opioid receptor function in the ventral 
tegmental area (Ellgren et al. 2007) and enhanced proenkephalin peptide in the nucleus 
accumbens in the adult period (Tomasiewicz et al. 2012). In addition, exposure to THC 
in adolescent male rats increased the self-administration of the synthetic cannabinoid 
WIN55,212-2 (Scherma et al. 2016). In this study, THC-treated animals showed a 
reduced capacity for WIN55,212-2 to increase dopamine levels in the nucleus accumbens 
shell during adulthood (Scherma et al. 2016). As a whole, the above-described preclinical 
studies suggest that THC chronic exposure during adolescence may induce long-term 
alterations in reward neural pathways and increase sensitivity to certain drug classes, such 
as opioids, when tested later in adulthood. However, the effects of adolescent THC on 
addiction vulnerability could not be generalized to all drugs of abuse.   
Stress and nicotine-associated cues exposure leading to nicotine relapse are crucial for 
the maintenance of tobacco addiction (Stoker and Markou, 2015; Mantsch et al. 2016). 
THC adolescent exposure did not modify cue- and footshock stress-induced reinstatement 
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of nicotine-seeking behaviour in adult mice. However, THC treatment during adolescence 
increased the reinstatement of heroin self-administration induced by cues but not stress 
(24 h food deprivation) in adult rats (Tomasiewicz et al. 2012). In a subsequent study, 
when a pharmacological stressor (yohimbine) was used to reinstate heroin self-
administration behaviour, the response of THC-treated rats was stronger in comparison 
with controls (Stopponi et al. 2014). These results suggest that the mechanisms by which 
adolescent THC could influence the relapse to drug-seeking behaviours in adulthood are 
complex, and may depend on several factors including the type of stimulus use to trigger 
relapse, the specific drug evaluated and the animal species.        
Similar to our results, other studies found no evidence of adverse affective or cognitive 
outcomes during adulthood due to adolescent THC treatment (Ballinger et al. 2015; 
Bruijnzeel et al. 2019; Saravia et al. 2019), suggesting that adverse effects associated with 
adolescent THC exposure might be also influenced by non-cannabinoid factors of 
cannabis use. Frequent concomitants of human cannabis use include psychiatric 
disorders, environmental stressors, and polysubstance use (Ketcherside and Filbey, 2015; 
Liu et al. 2018; Pinto et al. 2019). Indeed, the interaction between genetic or 
environmental events and cannabinoid exposure in the adolescent period can contribute 
to exacerbate behavioural deficits in adulthood (Rubino and Parolaro, 2016). Thus, 
adolescent mice treated with THC and exposed to stress exhibited impaired cued fear 
extinction in adulthood (Saravia et al. 2019), while no effect was observed in animals 
exposed to these two factors separately. Chronic adolescent treatment with THC induced 
a deficit in cued fear conditioning only in adult mice with a mutation in disrupted-in-
schizophrenia 1 gene (Ballinger et al. 2015). A possible interaction between adolescent 
THC and genetic/environmental factors that potentially alters the addictive properties of 
nicotine is an important issue that needs to be addressed in future research.    
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The use only of male mice is a limitation of this study since several reports show 
evidences for sex differences in the central effects of THC (Rubino and Parolaro, 2015; 
Cooper and Craft, 2018), although different results have been found depending on the 
response evaluated. These effects may depend on the different pharmacokinetics 
described for THC between males and females (Craft et al. 2017), the existence of 
different neurodevelopmental trajectories between both sexes (Lenroot et al. 2007), and 
interactions between the endocannabinoid system and sex hormones that could affect the 
maturation of the adolescent brain (Rubino and Parolaro, 2015). Specifically, the effects 
of adolescent cannabinoid exposure on adult drug self-administration seem to present sex-
dependency. Higher adult cocaine self-administration rates have been reported in adult 
female, but not male, rats treated with the synthetic cannabinoid CP55,940 (Higuera-
Matas et al. 2008). An increase in morphine self-administration under the fixed ratio 1 
schedule was also described in adult males, but not in females, exposed to the same 
synthetic agonist during the adolescent period (Biscaia et al. 2008). Therefore, the 
investigation about how males and females might differ in the effects of adolescent THC 
exposure in the addictive properties of nicotine will require special attention in the future. 
In summary, under our particular experimental conditions, these data did not reveal 
evidence for alterations in nicotine reward and relapse during adulthood due to adolescent 
THC exposure. These results do not support the gateway hypothesis in which prior 
cannabis facilitates a progression to tobacco dependence. Future research evaluating 
several aspects such as the interaction between THC and genetic/environmental factors, 
or the possible influence of sex will be necessary in order to better know the impact of 





Figure 1. A, Time schedule of THC exposure during adolescence, and nicotine self-
administration, extinction and drug-seeking reinstatement during adulthood. B, Total 
number of animals included in each experimental phase. PND, post-natal day.  
 
Figure 2. A, Body weight of mice during THC exposure (3, 6 and 12 mg/kg) and at the 
beginning of behavioural testing in adulthood (PND70). B, Body weight gain from 
PND49 (at the end of THC treatment) to PND70 (before surgery). Data are expressed as 
mean ± S.E.M. p<0.05, p<0.01 between treatments (Newman-Keuls test) (n = 36 
mice per group). VEH, vehicle. 
 
Figure 3. Acquisition and extinction of nicotine self-administration behaviour in animals 
previously exposed to THC or vehicle during adolescence. A, Mean number of nose-
poking responses displayed in the active and inactive holes during the acquisition period. 
Mice were trained daily to obtain 30 μg/kg/infusion under a FR1 schedule of 
reinforcement (n = 21-26 mice per group). B, Mean nicotine intake observed per animal 
for the whole acquisition period. C, Percentage of animals achieving all the acquisition 
criteria by the end of the acquisition period. D, Mean number of days required to reach 
all acquisition criteria. E, Mean number of nose-pokes displayed during extinction 
training (n = 21 mice per group). F, Percentage of animals reaching the extinction criterion 
after a 20-day extinction period. G, Mean days required to fulfil the extinction criterion. 
VEH, vehicle. Data are expressed as mean ± S.E.M. #p<0.05, ##p<0.01 between holes 




Figure 4. Reinstatement of nicotine self-administration behaviour in animals previously 
exposed to THC or vehicle during adolescence. A, Mean number of nose-poking 
responses displayed in the active and inactive holes during extinction and cue-induced 
reinstatement. Mice were re-exposed to nicotine-associated environmental cues at the 
beginning of the reinstatement session and after each active nose-poke, in the absence of 
nicotine (n = 9-10 mice per group). B, Mean number of nose-poking responses displayed 
in the active and inactive holes during extinction and stress-induced reinstatement. Mice 
were exposed to 5 footshocks delivered throughout 5 minutes immediately before the 
reinstatement session, which was performed in the same conditions than the extinction 
training (n = 9 mice per group). VEH, vehicle. Data are expressed as mean ± 
S.E.M. p<0.01, between experimental phases or between holes (Newman-Keuls 
test).  
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